StemCyte International, Ltd. (TPEX:4178)

StemCyte International Statistics

Total Valuation

TPEX:4178 has a market cap or net worth of TWD 4.71 billion. The enterprise value is 2.93 billion.

Market Cap	4.71B
Enterprise Value	2.93B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

TPEX:4178 has 192.21 million shares outstanding. The number of shares has increased by 26.54% in one year.

Current Share Class	192.21M
Shares Outstanding	192.21M
Shares Change (YoY)	+26.54%
Shares Change (QoQ)	-4.01%
Owned by Insiders (%)	9.87%
Owned by Institutions (%)	1.64%
Float	159.42M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	11.81
PB Ratio	2.78
P/TBV Ratio	2.79
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.45
EV / Sales	7.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-34.86

Financial Position

The company has a current ratio of 11.01, with a Debt / Equity ratio of 0.13.

Current Ratio	11.01
Quick Ratio	9.20
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-2.62
Interest Coverage	-16.29

Financial Efficiency

Return on equity (ROE) is -14.45% and return on invested capital (ROIC) is -9.19%.

Return on Equity (ROE)	-14.45%
Return on Assets (ROA)	-5.37%
Return on Invested Capital (ROIC)	-9.19%
Return on Capital Employed (ROCE)	-8.30%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.15
Inventory Turnover	0.62

Taxes

In the past 12 months, TPEX:4178 has paid 506,000 in taxes.

Income Tax	506,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	25.38
200-Day Moving Average	n/a
Relative Strength Index (RSI)	43.43
Average Volume (20 Days)	290,562

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4178 had revenue of TWD 398.60 million and -189.78 million in losses. Loss per share was -0.97.

Revenue	398.60M
Gross Profit	137.37M
Operating Income	-228.44M
Pretax Income	-189.27M
Net Income	-189.78M
EBITDA	-199.54M
EBIT	-228.44M
Loss Per Share	-0.97

Balance Sheet

The company has 2.00 billion in cash and 220.08 million in debt, giving a net cash position of 1.78 billion or 9.24 per share.

Cash & Cash Equivalents	2.00B
Total Debt	220.08M
Net Cash	1.78B
Net Cash Per Share	9.24
Equity (Book Value)	1.70B
Book Value Per Share	8.83
Working Capital	2.31B

Cash Flow

In the last 12 months, operating cash flow was -74.17 million and capital expenditures -9.97 million, giving a free cash flow of -84.14 million.

Operating Cash Flow	-74.17M
Capital Expenditures	-9.97M
Free Cash Flow	-84.14M
FCF Per Share	-0.44

Margins

Gross margin is 34.46%, with operating and profit margins of -57.31% and -47.61%.

Gross Margin	34.46%
Operating Margin	-57.31%
Pretax Margin	-47.48%
Profit Margin	-47.61%
EBITDA Margin	-50.06%
EBIT Margin	-57.31%
FCF Margin	n/a

Dividends & Yields

TPEX:4178 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.54%
Shareholder Yield	n/a
Earnings Yield	-4.03%
FCF Yield	-1.79%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4178 has an Altman Z-Score of 3.04 and a Piotroski F-Score of 3.

Altman Z-Score	3.04
Piotroski F-Score	3